Diffuse large B cell lymphoma other diagnostic studies

Jump to navigation Jump to search

Diffuse large B cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diffuse large B cell lymphoma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diffuse large B cell lymphoma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diffuse large B cell lymphoma other diagnostic studies

CDC on Diffuse large B cell lymphoma other diagnostic studies

Diffuse large B cell lymphoma other diagnostic studies in the news

Blogs on Diffuse large B cell lymphoma other diagnostic studies

Directions to Hospitals Treating Diffuse large B cell lymphoma

Risk calculators and risk factors for Diffuse large B cell lymphoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Optional procedures include head CT or brain MRI, lumbar puncture to analyze cerebrospinal fluid, and CT or PET-CT scans.

Other diagnostic studies

Optional procedures include[1]

  • Head CT or brain MRI
  • Lumbar puncture to analyze cerebrospinal fluid.
  • CT or PET-CT scans

Lesions smaller than 1 cm are not reliably visualized with PET scans. PET scan is now part of pre-treatment evaluation in diffuse large B cell lymphoma. The pre-treatment PET is particularly important to aid in the interpretation of post-treatment response evaluation according to new response criteria. PET scan has generally been used in conjunction with diagnostic CT scans.

References

  1. "Non-Hodgkin's Lymphomas (NCCN.org)" (PDF).


Template:WikiDoc Sources